Clinical Trial Update: The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients' Lipid Profiles [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy of a lipid-lowering tea in hyperlipidemia patients. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Lipid-Lowering Tea

Snippet

Sponsor: China Medical University Hospital | Conditions: Hyperlipidemia | Phase 3 | Status: UNKNOWN